WILLIAMS JONES & ASSOCIATES LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
WILLIAMS JONES & ASSOCIATES LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2019$686,000
-17.8%
5,700
-40.3%
0.01%
-22.2%
Q1 2019$835,000
+271.1%
9,550
+324.4%
0.02%
+200.0%
Q4 2018$225,000
-12.8%
2,2500.0%0.01%
+20.0%
Q3 2018$258,000
-12.8%
2,250
-44.4%
0.01%
-28.6%
Q1 2018$296,0004,0500.01%
Other shareholders
HAEMONETICS CORP shareholders Q1 2019
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders